Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Nu-Med Plus (NUMD) Equity Average (2016 - 2025)

Nu-Med Plus' Equity Average history spans 9 years, with the latest figure at -$101187.5 for Q4 2021.

  • On a quarterly basis, Equity Average fell 129.36% to -$101187.5 in Q4 2021 year-over-year; TTM through Dec 2021 was -$101187.5, a 129.36% decrease, with the full-year FY2021 number at $167672.5, up 244.75% from a year prior.
  • Equity Average hit -$101187.5 in Q4 2021 for Nu-Med Plus, down from -$35834.0 in the prior quarter.
  • Over the last five years, Equity Average for NUMD hit a ceiling of $344689.0 in Q4 2020 and a floor of -$2.2 million in Q1 2017.
  • Historically, Equity Average has averaged -$123097.1 across 5 years, with a median of -$24468.8 in 2017.
  • Biggest five-year swings in Equity Average: soared 426.12% in 2018 and later crashed 1060.06% in 2019.
  • Tracing NUMD's Equity Average over 5 years: stood at $56608.5 in 2017, then skyrocketed by 114.64% to $121505.5 in 2018, then plummeted by 377.29% to -$336922.0 in 2019, then soared by 202.31% to $344689.0 in 2020, then plummeted by 129.36% to -$101187.5 in 2021.
  • Business Quant data shows Equity Average for NUMD at -$101187.5 in Q4 2021, -$35834.0 in Q3 2021, and $94652.0 in Q2 2021.